Louisa Maria Bulirsch und Short-Term - Info zur Person

(1 - 6 von 7

)

Short-term real-world outcomes following intravitreal ...

bjo.bmj.com

von LM Bulirsch · · Zitiert von: 42 — Louisa Maria Bulirsch ; Marlene Saßmannshausen ; Jennifer Nadal ; Raffael Liegl ; Sarah Thiele ... von LM Bulirsch · · Zitiert von: 42 — Louisa Maria Bulirsch1, · Marlene Saßmannshausen1, · Jennifer Nadal2, · Raffael Liegl1, · Frank G Holz1. › › abstract

Short-term real-world outcomes following intravitreal ScienceGate

www.sciencegate.app

Louisa Maria Bulirsch ◽. Marlene Saßmannshausen ◽. Jennifer Nadal ◽. Raffael Liegl ◽. Sarah Thiele ◽ ... Keyword(s):. Real World ◽. › bjop...

Short-term real-world outcomes following PubMed

pubmed.ncbi.nlm.nih.gov

von LM Bulirsch · Zitiert von: 42 — Sep;106(9): doi: bjophthalmol Epub Apr 12. Authors. Louisa Maria Bulirsch , Marlene Saßmannshausen , Jennifer Nadal ... › ...

Short-term real-world outcomes following intravitreal Europe PMC

europepmc.org

Short-term real-world outcomes following intravitreal brolucizumab for neovascular AMD: SHIFT study. Louisa Maria Bulirsch. Department of Ophthalmology, ... › pmc › pm...

Short-term real-world outcomes following intravitreal brolucizumab...

medworm.com

CONCLUSIONS: The results of the SHIFT study indicate that switch to brolucizumab may represent a treatment option in patients with nAMD poorly responsive to...